Dermata Therapeutics (DRMA) Current Assets (2020 - 2021)
Dermata Therapeutics (DRMA) posted quarterly Current Assets of $11.6 million for Q4 2021, up 1819.87% year-over-year from $605453.0 in Q4 2020, and down 15.07% quarter-over-quarter from $13.7 million in Q3 2021.
Dermata Therapeutics (DRMA) Current Assets (2020 - 2021) Analysis & Trends
Dermata Therapeutics' Current Assets history runs 2 years deep, the most recent figure standing at $11.6 million for Q4 2021.
- In Q4 2021, Current Assets rose 1819.87% year-over-year to $11.6 million; the TTM figure through Dec 2021 stood at $11.6 million (up 1819.87% YoY), while the FY2021 annual figure was $11.6 million, up 1819.87% from the prior year.
- Current Assets for Q4 2021 stood at $11.6 million, down from $13.7 million in the prior quarter.
- The five-year high for Current Assets was $13.7 million in Q3 2021, with the low at $605453.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.76 Bn |
| 10 | Dermata Therapeutics | 5.44 Mn | 5.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 11.62 Mn |
| Sep 30, 2021 | 13.69 Mn |
| Jun 30, 2021 | 1.14 Mn |
| Dec 31, 2020 | 605,453.00 |